# Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/treatment-interruptions-and-non-adherence-with-imatinib-and-associated/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Theodore Darkow,Henry J. Henk,Simu K. Thomas,Weiwei Feng,Jean‐François Baladi,George A. Goldberg,Alan K. Hatfield,Jörge E. Cortes |
| Citations | 267 |
| DOI | 10.2165/00019053-200725060-00004 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1606656369 |
| PMID | 17523753 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Simu K. Thomas](https://scholariq.org/researchers/simu-k-thomas/)

## Paper journal

- [PharmacoEconomics](https://scholariq.org/journals/pharmacoeconomics/)

## Paper primary topic

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Paper topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.